China Cord Blood Corp. (NYSE:CO) was up 3.4% on Friday . The stock traded as high as $5.13 and last traded at $5.11, with a volume of 185,394 shares. The stock had previously closed at $4.94.

CO has been the topic of several research reports. Zacks Investment Research downgraded China Cord Blood Corp. from a “hold” rating to a “sell” rating in a report on Tuesday, July 19th. TheStreet downgraded China Cord Blood Corp. from a “buy” rating to a “hold” rating in a report on Thursday, August 4th. Five equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $7.00.

The company has a 50-day moving average of $5.38 and a 200-day moving average of $5.86. The stock has a market cap of $417.23 million and a P/E ratio of 27.86.

China Cord Blood Corp. (NYSE:CO) last issued its earnings results on Tuesday, June 14th. The company reported $0.03 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.03. The company had revenue of $24.30 million for the quarter. Analysts predict that China Cord Blood Corp. will post $0.17 earnings per share for the current fiscal year.

China Cord Blood Corporation is principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. The Company provides cord blood testing, processing and storage services under the direction of subscribers. The Company also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.